摘要
目的:了解肾移植患者丙型肝炎病毒(HCV)的感染情况及HCV感染后的临床影响。方法:对67例肾移植患者进行至少1年的随访,用第二代ELISA法和Nest-PCR测定血清中抗HCV和HCVRNA。结果:抗HCV的阳性率50.7%(34例),HCVRNA的阳性率为47.8%(32例)。HCVRNA阳性组术前血透时间和输血量及丙氨酸转移酶(ALT)水平明显高于HCVRNA阴性组,HCVRNA阳性组术前与术后ALT水平差异不显著。术后HCVRNA阳性组的ALT水平和肝脏损害的发病率明显高于HCVRNA阴性组,感染、排斥反应、移植物的存活率、肌酐水平在两组中差异不显著。结论:本研究显示,HCV感染主要影响肾移植患者的肝脏病变,在短期内对患者的感染、排斥反应、移植物的存活率无显著影响,表明HCV感染不是肾移植的禁忌证。
OBJECTIVE To evaluated the incidence and influence of HCV infection in renal transplantation.METHODOLOGY Sixty seven renal transplant patients were followed up for more than 1 year.Serum antibodies to HCV was detected by second generation ELISA and HCVRNA by Nest PCR.RESULTS The prevalence of antiHCV antibody was 507%(n=34),and the prevalence of HCVRNA was 478%(n=32).The patients with positive HCVRNA had a much longer duration of dialysis(P<005)and had received more blood transfusing before transplantation than patients with negative HCVRNA.No significant difference of ALT levels was found in this group of patients before and after transplantation.ALT level was significantly higher in HCVRNA positive patients than in HCVRNA negative patients.No differences in the rate of other infection,rejection rate,graft survival rate,and serum creatinine levels were found between HCVRNA positive and negative patients.CONCLUSION The rate of short term rejection and survival and the rate of other infections are not affected by the positivity of HCV antibodies and HCVRNA.
出处
《肾脏病与透析肾移植杂志》
CAS
CSCD
1998年第2期126-129,共4页
Chinese Journal of Nephrology,Dialysis & Transplantation